MKI67 and hepatocellular carcinoma: Previous studies have shown that patients with HCC with high Ki-67 expression have a significantly poor prognosis in terms of recurrence rates, overall survival (OS), disease-free survival (DFS), and relapse-free survival (RFS) [2, 3].